AA
Abhay Agrawal
About Abhay Agrawal
Data last updated:
Abhay Agrawal is a Director at Q-Line Biotech Limited (since 2015), Director at Heidelco Medicore Private Limited (since 2016) and Director at Poct Quality & Skill Development Foundation (since 2019), and holds 1 more current directorship. The companies operate in Healthcare and Education. The 3 current companies with reported revenue have a combined latest revenue of ₹373 Cr; the largest is Q-Line Biotech Limited at ₹322 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Jan 2015 | 2010 | ₹322 Cr (FY 2025) | Active | |
| Director | 10 Feb 2016 | 2013 | ₹51.23 Cr (FY 2024) | Active | |
| Director | 23 Dec 2019 | 2018 | ₹4.2 Lakh (FY 2024) | Active | |
| Director | 25 Jul 2025 | 2025 | Active |
Board colleagues of Abhay Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhishek Mishra | 08790634 | Q-Line Biotech Limited | Director |
| Ajay Kumar Mahanty | 07002517 | Q-Line Biotech Limited | Whole-Time Director |
| Akhand Pratap Singh | Q-Line Biotech Limited | Company Secretary | |
| Amita Garg | 02891610 | Q-Line Biotech Limited , Heidelco Medicore Private Limited and 1 more | Director |
| Ayush Garg | 08748016 | Q-Line Biotech Limited , Patheasy Diagnostics Private Limited | Director |
| Jai Prakash Singh | 10824246 | Q-Line Biotech Limited | Director |
| Kuldeep Chowdhry | 06504620 | Q-Line Biotech Limited | Whole-Time Director |
| Meenal Gupta | Q-Line Biotech Limited | Cfo | |
| Prabhakara Subraya Yethadka | 06922503 | Q-Line Biotech Limited | Whole-Time Director |
| Pravir Kumar | 00671671 | Q-Line Biotech Limited | Director |
| Rohit Nandan | 02195896 | Q-Line Biotech Limited | Director |
| Saurabh Garg | 02891621 | Q-Line Biotech Limited , Heidelco Medicore Private Limited and 1 more | Managing Director |
| Vishal Khanna | 09388945 | Heidelco Medicore Private Limited | Director |
| Puneet Gupta | 05213203 | Patheasy Diagnostics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abhay Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abhay Agrawal
Abhay Agrawal currently holds 4 directorships: Q-Line Biotech Limited (Director, since 12 Jan 2015, revenue ₹322 Cr (FY 2025)); Heidelco Medicore Private Limited (Director, since 10 Feb 2016, revenue ₹51.23 Cr (FY 2024)); Poct Quality & Skill Development Foundation (Director, since 23 Dec 2019, revenue ₹4.2 Lakh (FY 2024)); Patheasy Diagnostics Private Limited (Director, since 25 Jul 2025).
Abhay Agrawal was first appointed on 12 Jan 2015 as Director at Q-Line Biotech Limited. The most recent appointment on record is 25 Jul 2025 at Patheasy Diagnostics Private Limited.
The 3 current companies of Abhay Agrawal that report revenue have a combined latest revenue of ₹373 Cr: Q-Line Biotech Limited ₹322 Cr (FY 2025); Heidelco Medicore Private Limited ₹51.23 Cr (FY 2024); Poct Quality & Skill Development Foundation ₹4.2 Lakh (FY 2024).
The current boards of Abhay Agrawal's companies include Abhishek Mishra (Q-Line Biotech Limited), Ajay Kumar Mahanty (Q-Line Biotech Limited), Akhand Pratap Singh (Q-Line Biotech Limited), Amita Garg (Q-Line Biotech Limited), Ayush Garg (Q-Line Biotech Limited), Jai Prakash Singh (Q-Line Biotech Limited), among others.